Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
Saved in:
| Date: | 2021 |
|---|---|
| Main Authors: | M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchina, O. I. Kovzun, V. M. Pushkarev |
| Format: | Article |
| Language: | English |
| Published: |
2021
|
| Series: | Reports of the National Academy of Sciences of Ukraine |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001285363 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Glycemic control in prevention of cardiovascular diseases in diabetes mellitus
by: A. N. Korzh
Published: (2019)
by: A. N. Korzh
Published: (2019)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016)
by: A. Sahu, et al.
Published: (2016)
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Modeling of diabetes mellitus-related depression
by: H. Li, et al.
Published: (2014)
by: H. Li, et al.
Published: (2014)
Nanomaterials in the diagnostics and therapy of diabetes mellitus
by: M. V. Tolkachov, et al.
Published: (2015)
by: M. V. Tolkachov, et al.
Published: (2015)
The role of apoptosis in the combined course of chronic obstructive pulmonary disease and type 2 diabetes mellitus
by: N. K. Sukhonos
Published: (2017)
by: N. K. Sukhonos
Published: (2017)
Untitled
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Identification of genes involved in cardiovascular diseases
by: D. Abdusa
Published: (2016)
by: D. Abdusa
Published: (2016)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Sortylin influence on the indicators of carbohydrate metabolism at combination of coronary artery disease and type 2 diabetes mellitus
by: A. O. Sypalo
Published: (2017)
by: A. O. Sypalo
Published: (2017)
Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
by: O. Bondarenko, et al.
Published: (2016)
by: O. Bondarenko, et al.
Published: (2016)
Characteristics of Endothelial dysfunction in patients with Diabetes mellitus
by: A. S. Kuznetsova, et al.
Published: (2018)
by: A. S. Kuznetsova, et al.
Published: (2018)
The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014)
by: B. M. Mankovskyi, et al.
Published: (2014)
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)
by: T. S. Vatseba, et al.
Published: (2020)
Prospects for the use of umbilical cord blood in the treatment of diseases of the cardiovascular system
by: I. Y. Shchenyavskyi
Published: (2023)
by: I. Y. Shchenyavskyi
Published: (2023)
Prospects of gene therapy for the treatment of cardiovascular diseases
by: A. K. Gulevskij, et al.
Published: (2012)
by: A. K. Gulevskij, et al.
Published: (2012)
The role of apelin in the pathogenesis of cardiovascular and gastrointestinal diseases
by: V. P. Sinelnik
Published: (2015)
by: V. P. Sinelnik
Published: (2015)
Rrofile of proinflammatory cytokines in type 1 diabetes mellitus
by: Yu. H. Kyiak, et al.
Published: (2012)
by: Yu. H. Kyiak, et al.
Published: (2012)
Absolute insulin insufficiency in different variants of diabetes mellitus
by: T. M. Tikhonova, et al.
Published: (2018)
by: T. M. Tikhonova, et al.
Published: (2018)
Endothelial dysfunction and cerebrovascular pathology in patients with diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Cardiovascular complications in COVID-19: case report and concise review
by: N. Oryshchyn, et al.
Published: (2020)
by: N. Oryshchyn, et al.
Published: (2020)
The peculiarities of management of the patients with arterial hypertension in combination with diabetes mellitus
by: A. N. Korzh
Published: (2012)
by: A. N. Korzh
Published: (2012)
Innovative Proposals on the Implementation of Dietary Supplements for Diabetes Mellitus and Helicobacteriosis
by: I. P. Krysiuk, et al.
Published: (2018)
by: I. P. Krysiuk, et al.
Published: (2018)
The activity of the interneuron pools of the spinal cord in experimental diabetes mellitus
by: O. H. Rodynskyi, et al.
Published: (2013)
by: O. H. Rodynskyi, et al.
Published: (2013)
State of lipid peroxidation in patients with diabetes mellitus and erectile dysfunction
by: R. S. Rzaev
Published: (2021)
by: R. S. Rzaev
Published: (2021)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
The problem of adherence to long-term treatment of patients with cardiovascular diseases
by: E. A. Naumova, et al.
Published: (2014)
by: E. A. Naumova, et al.
Published: (2014)
Development and research of a genetic method for medical diagnosis of diabetes mellitus
by: Федорченко, Є. М., et al.
Published: (2021)
by: Федорченко, Є. М., et al.
Published: (2021)
Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
by: Ye. V. Opria
Published: (2018)
by: Ye. V. Opria
Published: (2018)
Development and research of a genetic method for medical diagnosis of diabetes mellitus
by: Ye. M. Fedorchenko, et al.
Published: (2021)
by: Ye. M. Fedorchenko, et al.
Published: (2021)
Similar Items
-
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021) -
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022) -
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)